Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 7/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | RAD52 | P43351 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.36 |
| ▸ | PAM | P19021 | 2/20 | 0.36 |
| ▸ | PPARG | P37231 | 5/20 | 0.35 |
| ▸ | PPARD | Q03181 | 5/20 | 0.35 |
| ▸ | PPARA | Q07869 | 5/20 | 0.35 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TLR2 | O60603 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | FABP4 | P15090 | 2/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8735298 | 0.80 | TDP1 (0.31) | BLMTSHRALDH1A1TDP1ALOX15 | |
| SCHEMBL10171416 | 0.74 | PLA2G2A (0.49) | PLA2G2ABLMNAAAHCAR2TSHR | |
| SCHEMBL345325 | 0.71 | PLA2G2A (0.46) | PLA2G2ABLMNAAAHCAR2TSHR | |
| SCHEMBL165060 | 0.71 | — | — | |
| SCHEMBL4765473 | 0.71 | TSHR (0.41) | PLA2G2ABLMHCAR2TSHRHPGD | |
| SCHEMBL30888739 | 0.69 | ZDHHC20 (0.47) | NAAAHCAR2TSHRHPGDALDH1A1 | |
| SCHEMBL7647191 | 0.69 | AKR1B1 (0.40) | TSHRAKR1B1PPARGPPARDPPARA | |
| SCHEMBL8198217 | 0.69 | GPR84 (0.48) | PLA2G2ABLMTSHRAKR1B1PPARG | |
| SCHEMBL8525433 | 0.69 | GPR84 (0.48) | PLA2G2ABLMTSHRAKR1B1PPARG | |
| SCHEMBL1347487 | 0.69 | HCAR2 (0.42) | PLA2G2ANAAAHCAR2TSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100093536-A1 | CONTROL OF GRASSY WEEDS WITH VINYLGLYCINES AND VINYLGLYCINE-PRODUCING ORGANISMS | THE STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER | 2010-04-15 | — | — | US | claimed |
| US-20100189798-A1 | CONTROL OF ERWINIA AMYLOVORA WITH VINYLGLYCINES AND BACTERIA THAT PRODUCE VINYLGLYCINES | THE STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF | 2010-07-29 | — | — | US | disclosed |
| US-20100093536-A1 | CONTROL OF GRASSY WEEDS WITH VINYLGLYCINES AND VINYLGLYCINE-PRODUCING ORGANISMS | THE STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER | 2010-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100093536-A1 | CONTROL OF GRASSY WEEDS WITH VINYLGLYCINES AND VINYLGLYCINE-PRODUCING ORGANISMS | GLO1, AGXT, GMDS | PLA2G2A 1432/4885BLM 1930/4885NAAA 225/4885 |
| US-20100189798-A1 | CONTROL OF ERWINIA AMYLOVORA WITH VINYLGLYCINES AND BACTERIA THAT PRODUCE VINYLGLYCINES | GLO1, MGAM, AGL | PLA2G2A 597/4885BLM 1359/4885NAAA 108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.